Analyses of the antiviral antibody responses in patients diagnosed with COVID-19 indicate that the seroconversion of SARS-CoV-2-targeted IgM and IgG antibodies can be detected within 13 days of symptom onset in nearly all patients with COVID-19 (9). The gene discussed is CD40LG; the disease is COVID-19.